Pure Global AI
ANVISA registration 10337990045Valid until Nov 23, 2030

IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS

ANVISA Registration Number: 10337990045LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA.LEICA BIOSYSTEMS NEWCASTLE LTDRisk Class III
Verified
Device names
Technical name
IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS
View exact technical-name matches →
PT: IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE CÉLULAS GERMINATIVAS
Commercial name
Família Anticorpo para Carcinoma Germinativo
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10337990045
Process Number
25351311162202073
CNPJ
52201456000113
Company information
Registration Holder
LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA.
Manufacturer
LEICA BIOSYSTEMS NEWCASTLE LTD
Manufacturing Country
United Kingdom
PT: REINO UNIDO
Dates and status
Publication Date
Nov 23, 2020
Validity
23/11/2030
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10337990045 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD. The registration is held by LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. with validity until Nov 23, 2030.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.